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Abstract: Three dermacozines, dermacozines N–P (1–3), were isolated from the piezotolerant Actino-
mycete strain Dermacoccus abyssi MT 1.1T, which was isolated from a Mariana Trench sediment in
2006. Herein, we report the elucidation of their structures using a combination of 1D/2D NMR, LC-
HRESI-MSn, UV–Visible, and IR spectroscopy. Further confirmation of the structures was achieved
through the analysis of data from density functional theory (DFT)–UV–Visible spectral calculations
and statistical analysis such as two tailed t-test, linear regression-, and multiple linear regression
analysis applied to either solely experimental or to experimental and calculated 13C-NMR chemical
shift data. Dermacozine N (1) bears a novel linear pentacyclic phenoxazine framework that has
never been reported as a natural product. Dermacozine O (2) is a constitutional isomer of the known
dermacozine F while dermacozine P (3) is 8-benzoyl-6-carbamoylphenazine-1-carboxylic acid. Der-
macozine N (1) is unique among phenoxazines due to its near infrared (NIR) absorption maxima,
which would make this compound an excellent candidate for research in biosensing chemistry,
photodynamic therapy (PDT), opto-electronic applications, and metabolic mapping at the cellular
level. Furthermore, dermacozine N (1) possesses weak cytotoxic activity against melanoma (A2058)
and hepatocellular carcinoma cells (HepG2) with IC50 values of 51 and 38 µM, respectively.
Keywords: deep sea natural products; Mariana Trench; Dermacoccus abyssi MT 1.1T; 13C-NMR chemi-
cal shift linear and multiple regression; (DFT)-UV-Vis spectral calculation; phenoxazine; dermacozine;
absorption maxima in the near infrared region
1. Introduction
Deep sea habitats have been shown to be an invaluable source of novel bacterial
species [1]. Extreme environments (e.g., hyper-arid deserts, bathyal and hadal zones, hot
volcanic lakes etc.) are capable of genetically segregating organisms due to their physical
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properties. Evolutionary adaptations to these extreme environments have generated
novel biosynthetic pathways in extremophiles, giving novel structures that may find
use in treating diseases [2–4]. Dermacoccus abyssi MT 1.1T (Figure 1) is a piezotolerant
Actinomycete isolated in 2006 from a Mariana Trench sediment, collected at a 10,898 m
depth from the Challenger Deep by the remotely operated submersible Kaiko in 1998 [5].
Figure 1. Scanning electron micrograph of the strain Dermacoccus abyssi MT 1.1T (Zeiss Gemini
SEM 300).
Seven novel phenazines, dermacozines A–G (4–10), as novel phenazines originating
from Dermacoccus abyssi strains MT 1.1T and MT 1.2 were reported by our group in 2010.
Subsequently, another four new derivatives: dermacozines H–J (11–13) and dermacozine
M (14) were isolated and reported with the contribution of our group in 2014 and 2020,
respectively (Figure 2) [6–8].
Figure 2. Chemical structures of known dermacozines (4–14) previously isolated from Dermacoccus
abyssi MT 1.1T and MT 1.2.
These highly pigmented dibenzo annulated pyrazines has kept our interest piqued
toward finding further unknown derivatives. Properties of the previously discovered
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dermacozines include their radical scavenging ability, cytostatic activity against the K562
leukemia cell line, and theoretically calculated non-linear optical behavior [6–9]. Their IC50
cytotoxic activities were reported to be in the range from 7 to 220 µM against the K562
chronic myelogenous leukemia cell line; structure–activity relationship studies revealed
a strong connection between the phenazine core linked to a cyclic carboxylic anhydride
with their increased activity, but no positive correlation was found in relation to the
carboxamide, lactone, or benzoyl moieties [10]. Recently, a synthetic study revealed
that the modulation of dermacozine-1-carboxamides, especially with electron releasing
substituents (e.g., chloro- and methoxy groups) increases the in vitro anti-tubulin activity of
dermacozine-1-carboxamide derivatives comparable to or even superior to the nocodazole
control. This evidence gave us reason to further investigate this strain for additional
bioactive dermacozine derivatives [11].
2. Results and Discussion
Dermacoccus abyssi MT 1.1T was phenotypically characterized following the initial
isolation from the Mariana Trench sediment; the strain is capable of growing in the presence
of 7.5% NaCl, which makes the strain halotolerant [5]. The production of new secondary
metabolites has been reported by several authors when salt was added to the culture
medium of the organisms capable of living in those conditions [12]. Xie et al. reported
the isolation of a new sesquiterpene, ascotrichic acid, when the marine-derived fungus
Ascotricha sp. ZJ-M-5 was cultivated in 33 g/L ocean salt containing medium [13]. In
our recently published article on the full genome sequence of Dermacoccus abyssi MT 1.1T
and the isolation of dermacozine M (14), the strain was cultivated in a GYE seed culture
medium initially, then subsequently large-scaled in 35 g/L ocean salt containing ISP2
medium [8]. Altering the preculture conditions has been shown to change the productivity
of the strain when dermacozines H–J (11–13) were isolated [7]. Herein, we report on the
isolation of further three dermacozines (1–3) produced by the strain Dermacoccus abyssi MT
1.1T when a seed culture is grown in ISP2 medium containing 20 g/L NaCl, followed by
a 35 g/L ocean salt supplemented ISP2 large-scale culture to approximate the deep-sea
salinity of 34.7‰ [14].
2.1. Structure Determination of Dermacozine N (1)
Dermacozine N (1) was isolated as a pink amorphous powder. The molecular for-
mula of 1 was established as C21H15O3N5 from LC-HRESI-MSn of the [M + H]+ ion at
m/z 386.1247 (calculated m/z 386.1248, ∆ = −0.3 ppm) and its 13C-NMR spectral data,
corresponding to 17 degrees of unsaturation.
The analysis and the comparison of the molecular formula and calculated DBE with the
previous metabolites reported from the same species along with its intense color suggested
that 1 must be a dermacozine-like molecule. The presence of the characteristic phenazine
substructure (ABC rings) in 1—bearing two carboxamide groups in this particular case—
present in most dermacozine structures, was deduced from the NMR data analysis and
comparison to those of the reported dermacozines.
Thus, the 1H-NMR spectrum of 1 showed the presence of an N-methyl group at δH
3.68 (3H, s, H-23), which has been a canonical part of the dermacozine structures thus far.
The 1H-13C HMBC correlations from the H-23 methyl hydrogens at δH 3.68 to δC 134.4
(C-4a) and δC 135.5 (C-5a), confirmed the position of the N-methyl group in the pyrazine
ring (B ring) of the phenazine core.
In accordance with other dermacozine structures bearing the phenazine substructure,
the 1H-1H COSY of 1 revealed two characteristic aromatic signals corresponding to the
aromatic A and C rings. The spin system with resonances at δH 7.88 (1H, dd, J = 7.6 and
1.3 Hz, H-2), 7.47 (1H, td, J = 8.3, and 7.6 Hz, H-3), and 7.55 (1H, dd, J = 8.3 and 1.3 Hz,
H-4) were indicative of a trisubstituted A aromatic ring. The aromatic proton signals of the
A and C rings were correlated to their corresponding carbon resonances at δC 125.9 (C-2),
128.4 (C-3), 118.0 (C-4), and 105.9 (C-9), respectively, through a 1H-13C HSQC experiment.
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1H-13C HMBC correlations from H-2 at δH 7.88 to δC 166.3 (C-11), δC 118.0 (C-4), and δC
135.1 (C-10a); from H-3 at δH 7.47 to δC 128.9 (C-1) and δC 134.4 (C-4a); from H-4 at δH 7.55
to δC 125.9 (C-2) and δC 135.1 (C-10a) allowed us to fix the positions of the methines at C-2,
C-3, and C-4 in relation to the non-protonated carbons at C-1, C-4a, and C-10a confirming
the structure of the A ring (see ring system in Figure 3).
Figure 3. Atom numbering for dermacozine N (1), dermacozine O (2), and dermacozine P (3).
On the other hand, a sharp singlet at δH 6.79 (1H, s, H-9), correlating to its corre-
sponding carbon resonance at δC 105.9 (C-9), by a 1H-13C HSQC experiment, suggested
the presence of a penta-substituted aromatic ring assigned to the C ring. The long range
1H-13C HMBC correlations from H-9 hydrogen at δH 6.79 to δC 151.6 (C-9a), δC 135.5 (C-5a),
and δC 149.8 (C-8) were pivotal for the structure elucidation of the C aromatic ring as they
were consistent with the linear annulation of the phenoxazine structure (Figure 4).
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The presence of the two carboxamide groups in 1, as in most dermacozine structures,
was deduced from a 1H-15N-NMR HMBC experiment showing two amide nitrogens at
δN 112.6 and 118.7 that correlate to their corresponding 1H-NMR signals at δH 7.70 (brs,
NH-12a)/9.31 (brs, NH-12b) and δH 7.65 (brs, NH-14a)/7.98 (brs, NH-14b). However, only
the C-11 amide carbonyl carbon at δC 166.3 could be detected in the 13C-NMR spectrum
of 1. The 1H-1H COSY correlations between the two NH2 hydrogens corresponding to
each carboxamide group and the characteristic N–H stretch signal at 3439 cm−1 detected
in the IR spectrum of 1 confirmed the presence of the two carboxamide groups in 1. The
two carboxamide groups were linked to C-6 and C-1 positions in 1 shown by the 1H-13C
HMBC correlations from the NH-14b hydrogen at δH 7.98 (brs) to C-6 at δC 109.8 and from
the H-2 hydrogen at δH 7.88 (dd) to the carbonyl of the carboxamide C-11 at δC 166.3, along
with the 1H-1H NOESY correlation from NH2-12 to H-9.
Once the phenazine substructure of 1 was confirmed, further NMR analysis allowed
us to establish the remaining part of the molecule.
Eight aromatic carbons were found to be connected to heteroatoms. Four aromatic
carbons at δC 134.4 (C-4a), 135.5 (C-5a), 151.6 (C-9a), and 135.1 (C-10a), linked to nitrogen
atoms, were already located in the B ring and the two aromatic carbons—at δC 149.8 (C-8)
linked to an oxygen atom, and 148.1 (C-7) linked to a nitrogen atom—were placed in the
C ring. The locations of the two remaining aromatic carbons connected to heteroatoms
with δC values of 143.3 (C-15) and δC 134.8 (C-20), attached to oxygen and nitrogen atoms,
respectively, were determined as follows.
The 1H-NMR spectrum of 1 also displayed the presence of an ortho-substituted ben-
zene ring (E ring) by the aromatic proton resonances at δH 7.30 (1H, dd, J = 7.6 and 1.6 Hz,
H-19), 7.15 (1H, ddd, J = 7.6, 7.4, and 1.5 Hz, H-18), 7.19 (1H, ddd, J = 7.6, 7.4, and 1.6 Hz,
H-17), 7.12 (1H, dd, J = 7.6 and 1.5 Hz, H-16), which were correlated to their corresponding
carbons at δC 127.2 (C-19), 125.3 (C-18), 127.9 (C-17), and, 115.0 (C-16), respectively, demon-
strated by the 1H-13C HSQC spectrum of 1. The non-protonated carbons at δC 143.3 and δC
134.8, assigned to the C-15 and C-20 carbons, respectively, completed the ortho-substituted
benzene substructure of the E ring. Theoretical chemical shift increment values are con-
sistent with an sp3 oxygen atom substitution at C-15, whereas the C-20 chemical shift
supports an sp2 nitrogen atom substituent [15]. The carbons C-16 and C-18 are ortho and
para position to the nearby oxygen atom, respectively, which possesses two lone pairs of
electrons and participate in the positive mesomeric effect, resulting in the shielded carbon
(and hydrogen) atoms at these positions. Key 1H-13C HMBC correlations from δH 7.12
(H-16) to C-15 (δC 143.3), C-20 (δC 134.8), and C-18 (δC 125.3); from δH 7.19 (H-17) to C-15
and C-19 (δC 127.2); from δH 7.15 (H-18) to C-16 (δC 115.0) and C-20; and from δH 7.30
(H-19) to C-15 and C-17 (δC 127.9) confirmed the ortho-substituted benzene ring.
The 106 unit mass loss observed in the LC-HRESI-MS/MS of 1, which matched with a
loss of a (-ON(C6H4)-) fragment agrees with the presence of this ortho-substituted aromatic
E ring in 1 (Figures S2 and S3A). The presence of an electron rich π-electron configuration
in the vicinity could explain why the C-6 carbon in the structure of 1 at δC 109.8 is shielded
in relation to the other dermacozines lacking that ring.
According to the literature in polycyclic aromatic hydrocarbons when five benzene
rings are annulated to each other in a linear fashion like in pentacene, the UV-Visible
absorption maxima in the visible electromagnetic spectrum compared to the angularly
fused benzo[a]anthracene shows bathochromic shift [16,17]. The UV–Vis spectra of der-
macozine E (8), F (9), G (10), and M (14)—exhibiting angular annulation of four rings as
seen in benzo[a]anthracene—displayed absorption maxima at 576, 566, 580, and 590 nm in
the visible electromagnetic spectrum, respectively [6–8]. Consequently, the bathochromic
shift displayed by the UV–Vis absorption maxima of 1 at 729 and 660 nm supports the
annulation of its five aromatic rings. Thus, dermacozine N (1) shows a higher extended
conjugation than that of dermacozine E (8), dermacozine F (9), dermacozine G (10), and
dermacozine M (14), which were the dermacozines with the longest visible absorption max-
ima in their UV–Vis spectra observed to date. Based on this UV–Vis spectral comparison,
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the core phenazine structure of 1 must be annulated with the (-ON(C6H4)-) substructure.
The correlations observed in the 1H-1H NOESY spectrum of 1 were crucial confirming
this result. The calculated ca. 2.8 Å distance between H-9 and NH2-12a and NH2-12b
hydrogen atoms in the molecular model enabled the linear fusion of the A/B/C/D/E
rings (Theme S1).
In order to support the proposed structure for 1, we carried out a linear regression
analysis and (DFT)–UV–Vis spectral simulation as follows.
Twenty-three possible structures of 1 (A–W) could be drawn in ACD Labs (Figures S34–
S38), satisfying the molecular formula of C21H15O3N5, the 1H-NMR splitting pattern, 2D
NMR, 15N-NMR, and the presence of the (-ON(C6H4)-) substructure connected to the core
phenazine in an angular or linear fashion. The phenazine biosynthesis occurs through the
Shikimic acid pathway and with this as the suggested route of dermacozine biosynthesis,
ten structures containing more heteroatoms in the phenazine core than N-5 and N-10
corresponding to B, C, F, L, M, O, R, S, T and U were excluded as possible solutions to
the current structure. The remaining thirteen possible structures (A, D, E, G, H, I, J, K,
N, P, Q, V, W) were subjected to statistical analysis. Their 13C-NMR chemical shifts were
calculated using the ACD Labs software simulation with the Neural Network Algorithm
and then the obtained values were subjected to linear regression with the experimental
13C-NMR data of 1. Linear regression between experimental and ACD Labs software
predicted 13C-NMR chemical shifts has been shown to be an effective method in predicting
the correct structures of natural products [18–20]. The strongest correlation was observed
for structure W (12-methyl-12H-quinoxalino[2,3-b]phenoxazine-8,13-dicarboxamide) with
R2 = 0.99 (Figure 5), which matched the proposed structure of dermacozine N (1), as shown
in Figure 4.
Figure 5. Correlation between experimental 13C-NMR chemical shift values (ppm) of dermacozine
N (1) and those of structure W (ACD Labs software (ACD/Structure Elucidator, version 2019.2.0,
Neural Network Algorithm, DMSO-d6).
Additionally, we carried out (DFT)–UV–Vis spectral calculations with the proposed
structure of 1 and its second and third most likely isomer structures based on the afore-
mentioned linear regression model (structures K and Q, R2 = 0.92 and 0.91, respectively).
Time-dependent DFT approach (TDDFT) calculations were used for generating the UV spec-
tra. First, a conformational search of structures K and Q was performed in the Macromodel
module implemented in Maestro Quantum mechanical software (Schrödinger). Using a
4.0 kcal/mol energy threshold from global minimum, ten and eight conformers were found,
respectively. The geometry of all these conformers was optimized and their corresponding
frequencies were calculated by using a density functional theory (DFT) method at the
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HSEH1PBE/cc-pVDZ level (see Section 3.4). The resulting UV spectra were combined by
Boltzmann weighting to give the composite spectra displayed in Figure 6 [21–23].
Figure 6. Conformers obtained from the conformational search for (a) structure W and structures
(c) K and (e) Q; DFT calculated UV–Vis spectra of structures (b) W (
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er ac zi e (1) is 12-methyl-12H-quinoxalino[2,3-b]phenoxazin -8,13-dicarboxamide.
To the best of our knowledge, the framework of dermacozine N (1) is unprecedented
in natural product chemistry. A synthetic compound bearing the same oxazinophenazine
skeleton present in dermacozine N (1) was reported by Fischer and Hepp in 1895. The
skeleton of this compound, referred to as “triphenazinoxazine” in the 19th century was
synthesized through nucleophilic substitution of 2-amino-3-phenoxazinone with ortho-
phenylenediamine [24]. The solvatochromic behavior of the oxazinophenazine and its
derivatives in different solvents and the spectacular bathochromic color change upon
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addition of strong acids and a subsequent hypsochromic shift when this solution was mixed
with glacial acetic acid has been described by various authors in the 19th century [24–28].
Fischer and Hepp observed dark red fluorescence of the “triphenazinoxazine” in “alcohol
solution” and the aforementioned color change from red to violet upon making the solution
acidic with mineral acids. In those times, induline derivatives with fluorescent properties
were listed under the collective name of “Fluorindine”-s [24–28]. In 1978, G.B. Afanas‘eva
et al. reported the synthesis of the same oxazinophenazine skeleton when they carried out
nucleophilic substitution of 2-ethoxy-3-phenoxazinone with ortho-phenylendiamine [29].
Given the compound absorption maxima of 1 in the near infrared spectrum (NIR), its
fluorescence spectroscopic investigation would be intriguing in the future.
Fluorophores from nature have gained particular interest among scientists in visu-
alizing physiological processes at the cellular level as the example of one of the most
notable discoveries in this field—the isolation of the green fluorescent protein (GFP)—
shows [30]. Phenoxazines were found to generate second harmonics (SHG, i.e., frequency
doubling) whilst being investigated for non-linear optical properties [31]. Utilizing the opto-
electronic features of phenoxazines is widespread in the literature. Benzo[a]phenoxazines
have been reported to possess useful NIR absorption and emission spectral features
as well as solvatochromic effects, thus making them useful in biosensing chemistry
(e.g., in pH sensing, glucose sensing, organic biomolecule labelling, and in vivo cellu-
lar metabolic mapping [32–39]). Utilizing the long wavelength absorption and emission
maxima in visualizing biological processes at the cellular level with fluorogenic probes
has gained extreme importance in recent years [37–39]. The absorption maxima of the
current benzo[a]phenoxazine probes is just about or under 700 nm whereas dermacozine
N (1) at 729 nm possesses the longest absorption maximum in the visible electromagnetic
spectrum among the phenoxazines currently being utilized for this purpose [36]. Biosensor
molecules exhibiting red or NIR wavelength absorption and emission maxima, as in the
case of dermacozine N (1), are required for the study of body fluids such as blood, serum,
and urine where the matrix may possess components with long wavelength absorption
maxima that can interfere with spectroscopic measurements [33].
The cytotoxic activity of dermacozine N (1) was investigated against a panel of five
human tumor cell lines: human melanoma (A2058) and hepatocellular human carcinoma
cell lines (HepG2) exhibiting weak activity, with IC50 values of 51 and 38 µM, respectively.
Certain phenoxazine derivatives (e.g., Nile Blue analogues were shown to be useful in vitro
in photodynamic therapy (PDT) against human bladder carcinoma cells (MGH-U1) acting
via the singlet oxygen (1O2) pathway [40]. In addition to its cytotoxicity, the NIR absorption
maxima of dermacozine N (1), which would interfere less with the tissue absorption
maxima as detailed above, suggests that it may be a suitable compound for further research
in the field of photodynamic therapy.
2.2. Structure Determination of Dermacozine O (2)
Dermacozine O (2) was isolated as an ink-blue amorphous powder. The LC-HRESI-
MSn measurement gave an m/z of 398.1125 for [M + H]+, consistent with a molecular
formula of C23H15O4N3 (calculated m/z 398.1135, ∆ = −2.5 ppm), giving 18 degrees of
unsaturation. Interestingly, this molecular formula matches that of previously reported
dermacozine F (9).
Comparison of the NMR spectra of dermacozine O (2) to those of dermacozines E and
F (8 and 9) showed the same A, B, C, and E rings for the three compounds. Indeed, the spin
systems identified in the 1H-1H COSY spectra of 8 and 9 had high similarity to the one in 2.
The first spin system belonging to the A ring (see ring system in Figure 3) was
assigned to the H-2, H-3, H-4 hydrogens, which were correlated to their corresponding
carbons according to the 1H-13C HSQC experiment with δH/ δC resonances at 7.87 (1H, dd,
J = 7.5 Hz, 1.1 Hz)/126.6 (C-2); 7.78 (1H, td, J = 8.5 Hz, 7.5 Hz)/ 131.3 (C-3); 7.97 (1H, dd, J
= 8.5 Hz, 1.1 Hz)/120.3 (C-4). The structure of the A ring was confirmed by the following
1H-13C HMBC correlations: from H-2 at δH 7.87 to C-11 at δC 167.2, C-4 at δC 120.3, and
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C-10a at δC 135.3; from H-3 at δH 7.78 to C-1 at δC 129.6 and C-4a at δC 134.0; and from
H-4 at δH 7.97 to C-2 at δC 126.6 and C-10a at δC 135.3. Furthermore, these correlations
clearly confirmed the C-1, C-2, C-3, and C-4a, C-10a positions of the A ring in relation to
the neighboring pyrazine moiety (B ring).
A methyl group that resonates as a sharp singlet at δH 3.67 (3H, s, H-23) in the 1H-
NMR spectrum of 2, correlated by 1H-13C HSQC to δC 45.9 (C-23), which was assigned
to the characteristic N-methyl attached to the pyrazine ring (B ring). The position of
this N-methyl group relative to the pyrazine ring was confirmed by the 1H-13C HMBC
correlations from H-23 at δH 3.67 to C-4a at δC 134.0 and C-5a δC 139.5.
The second spin system located in the C ring was found to be composed of the H-8
and H-9 hydrogens at δH 7.21 (1H, d, J = 9.7 Hz) and 7.24 (1H, d, J = 9.7 Hz), which
were correlated to δC 134.5 (C-8) and δC 129.7 (C-9), respectively, by the 1H-13C HSQC
experiment. The positions of the H-8/H-9 spin system relative to the C-5a, C-9a, C-6, C-7
in the C ring were confirmed by key 1H-13C HMBC correlations from H-9 at δH 7.24 to
C-5a at 139.5 ppm, from H-8 at δH 7.21 to C-9a at δC 150.6, C-6 at δC 100.4, C-7 at δC 139.6,
and C-16 at δC 122.6.
A monosubstituted benzene ring was assigned to the third spin system comprising the
five hydrogens corresponding to the E ring: H-18/22 at δH 7.30 (2H, dd, J = 7.4, 1.3 Hz)/δC
131.3 (C-18/22); H-19/21 at δH 7.47 (2H, td, J = 7.4, 1.3 Hz)/ δC 128.2 (C-19/21); and
H-20 δH 7.41 (1H, td, J = 7.4, 1.3 Hz)/δC 127.9 (C-20). The key 1H-13C HMBC correlation
from H-18/22 at δH 7.30 to C-16 at δC 122.6 ppm allowed us to confirm the connection of
the monosubstituted benzene E ring to C-16 of the probable D ring consisting of a cyclic
carboximide (Figure 7).
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C-11 at δC 167.2, the lack of signals in the 1H-NMR spectrum of 2, corresponding to the
NH2 group observed in dermacozines E and F (8 and 9), was indicative of the absence of
the C-11 carboxamide group in 2. This information, along with the fact that dermacozine F
(9) has the sa e molecular formula as compound 2, is indicative that the C-11 carboxamide
group present in 9 was substituted by a C-11 carboxylic acid in 2.
Upon assembling the A–E rings, the structure of dermacozine O (2) was determined
to be a constitutional isomer of dermacozine F (9) and the biosynthetically more closely
related C-1 carboxylated derivative of dermacozine E (8) with the IUPAC name of 12-
methyl-1,3-dioxo-4-phenyl-1,2,3,12-tetrahydropyrido[3,4-a]phenazine-8-carboxylic acid.
Dermacozine O (2) is the first isolated compound bearing a carboxylic acid in its structure
among the dermacozine E (8), F (9), G (10), and M (14) type of structures.
Due to the absence of some experimental 13 NMR signals, we carried out an ACD
Labs si ulation u ing the Neural Network Algorithm, which provided the chemical shift
carbon values for the carbonyl resonances of the cyclic carboximide moiety of 2 at δC 163.6
(C-13) and δC 163.1 (C-15), in perfect agreement with the C-13 and C-15 carbon shifts of the
aforementioned resembling dermacozine structures.
Dermacozine O (2) displayed no cytotoxic activity when tested against A549 (lung
carcinoma), A2058 (metastatic melanoma), MCF7 (breast adenocarcinoma), MIA PaCa-2
(pancreatic carcinoma), and HepG2 (hepatocyte carcinoma) cell lines.
The compound as discussed above resembles the structures of 8, 9, and 10, which
have been found to exhibit the strongest non-linear optical properties in computational
chemistry studies among the previously isolated dermacozines [9].
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Following the initial isolation of the dermacozines from the producing Dermacoccus
abyssi MT 1.1T and MT 1.2, their function in nature has not yet been determined [6–8]. Since
the survival capability of bacteria that produce the phenazine type of compounds is greater,
these compounds are proposed to have defensive functions that protect the producing
organism [6,41]. By looking at the structures of dermacozine N (1) and dermacozine O
(2) alongside the previously published dermacozines E (8), F (9), G (10), and M (14), the
quinonoid C rings resemble the quinones playing important roles in electron shuttling in
the respiratory process of the cell. Quinone derivatives are found in almost every living
organism’s lipid membrane with rare exceptions [42]. Certain phenazine derivatives have
been reported to be able to mediate electron transfer from NADPH to molecular O2 [43].
The function of dermacozines in nature is still unknown, but based on this observation,
their participation in redox reactions helping the strain to survive (e.g., in microaerobic
conditions) is potentially possible. This seems to be supported by the fact that the genome
sequence of the bacterium revealed the existence of cytochrome d oxidase, which exhibits
high affinity to O2 and operates under low oxygen concentrations and multiple copies
of succinate dehydrogenases, which can be used as electron donating systems in oxygen
deprived conditions [8].
2.3. Structure Determination of Dermacozine P (3)
Dermacozine P (3) was isolated as a purplish amorphous powder. The LC-HRESI-
MSn of 3 showed a protonated [M + H]+ ion at m/z 372.0990 [M + H]+, consistent with
a molecular formula of C21H13O4N3 (calculated m/z 372.0979, ∆= 3.0 ppm), possessing
17 degrees of unsaturation.
The 1H-1H COSY spectrum displayed the presence of three spin systems. The first
spin system assigned to the A ring comprises the three aromatic hydrogens at δH 8.74
(1H, dd, J = 7.0 and 1.3 Hz, H-2), 8.21 (1H, td, J = 7.0 and 8.6 Hz, H-3), and 8.55 (1H, dd,
J = 8.6 and 1.3 Hz, H-4). Key long range correlations in the 1H-13C HMBC spectrum of 3
from H-2 at δH 8.74 to C-10a at δC 141.2; from H-3 at δH 8.21 to C-1 at δC 131.5 and C-4a
at δC 142.4; and from H-4 at δH 8.55 to C-10a at δC 141.2 and C-2 at δC 134.9, defined the
H-2/H-3/H-4 spin system relative to quaternary C-4a and C-10a carbon atoms, completing
the substructure of the A ring (see ring system in Figure 3).
A second spin system corresponded to the aromatic hydrogens H-7 and H-9 with
resonances at δH 8.65 (1H, d, J = 1.9 Hz) and 8.95 (1H, d, J = 1.9 Hz). The 4JH7/H9 coupling
constant of 1.9 Hz, indicative of a meta relationship between these hydrogen atoms, along
with 1H-13C HMBC correlations from H-7 to C-5a at δC 140.7, C-9 at δC 135.1, C-13 at δC
166.6 and from H-9 to C-15 at δC 194.4, C-7 at δC 131.3, and C-5a at δC 140.7 allowed us to
determine the substructure of the C ring (Figure 9).
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The ar matic hydrogens H-17/21, H-18/20, and H-19 at δH 7.95 (2H, dd, J = 7.6 Hz
and 1.3 Hz); 7.66 (2H, td, J = 7.6 Hz and .3 Hz), and 7.78 (1H, td, J = 7.6 Hz and 1.3 Hz)
of the third spin system were assigned to a monosubstituted benzene corresponding to
the D ring. Those hydrogens were correlated to their corresponding carbons at δC 130.0
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(C-17/21), δC 128.7 (C-18/20), and δC 133.5 (C-19) by a 1H-13C HSQC experiment of 3.
Finally, C-16—the connection point of the monosubstituted benzene at δC 136.3—was
identified by the 1H-13C HMBC spectrum.
In contrast to all the dermacozine structures (4–14) reported thus far, the 1H-NMR
spectrum of 3 showed no evidence of the characteristic N-methyl group attached to the
pyrazine ring (B ring). Three out of the four carbon atoms of the B ring were assigned next
to nitrogen: δC 142.4 (C-4a), δc 140.7 (C-5a), and δC 141.2 (C-10a).
When the 1H-13C HSQC and 1H-13C HMBC spectra of 3 were overlaid, the presence of
three carbonyl carbons at δC 165.5 (C-11), δC 166.6 (C-13), and at δC 194.4 (C-15) was revealed.
One of them, C-13, was assigned to a carboxamide substituent from the characteristic primary
amide protons that resonate as two broad singlets at δH 8.03 (1H, brs, H-14a) and δH 9.47
(1H, brs, H-14b), both correlated in the 1H-1H COSY spectrum. The IR band at 3440 cm−1
corresponding to a NH stretching confirmed the existence of that substituent. The 1H-13C
HMBC correlation from H-7 at δH 8.65 to C-13 at δC 166.6, along with enhancement of the
H-17/21 aromatic protons at δH 7.95 by selective NOE irradiation at the NH-14a at δH 8.03,
allowed us to link the carboxamide substituent to position C-6 of the C ring.
The C ring of the phenazine moiety was connected at C-8 to a monosubstituted
benzene D ring at C-16 through the C-15 ketone carbonyl group at δC 194.4, confirmed
by the 1H-13C HMBC correlations from the H-9 and H-17/21 protons at δH 8.95 and 7.95,
respectively, to C-15. The already mentioned meta-coupling (4J = 1.9 Hz) between H-7 and
H-9 of the C ring also supports the attachment of C-15 to C-8 (Figure 9).
The 13C-NMR chemical shifts of C-6, C-8, and C-9a in 3 were not detected, so these
missing values were calculated with ACD Labs software, with the Neural Network Al-
gorithm as δC 129.8, 135.6, and 144.0 ppm, respectively. Upon assembling the structure
of 3, we had one more carbonyl group left with a δC of 165.5 ppm (C-11). Taking into
consideration the molecular formula, it was assigned to a carboxylic acid functionality. The
connection of this –COOH group was deduced from the 1H-13C HMBC correlation from
H-2 at δH 8.74 to C-11 at δC 165.5. The carboxylic OH-12 was not observed in the 1H-NMR
spectrum of 3 in DMSO-d6, therefore we applied a similar approach as in the case of 1 and
2 to confirm the proposed structure for 3.
We modeled dermacozine P (3) with the ACD Labs software (Neural Network Algo-
rithm, DMSO-d6) and the linear regression curve was obtained between the calculated and
experimentally observed 13C-NMR chemical shifts. The statistical analysis provided an
R2 = 0.98 (Figure 10).
Figure 10. Correlation between the ACD Labs calculated (version 2019.2.0, Neural Network Al-
gorithm, in DMSO-d6) and experimental 13C-NMR chemical shift values (ppm) of dermacozine
P (3).
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Upon comparison made between the experimental 13C-NMR shifts of 3 versus those
chemical shifts observed in the case of 5 and 6, we could observe a negative mesomeric
effect due to the carboxylic group at ortho- and para positions relative to that functionality
in the case of 3 (Figure 11).
Figure 11. Experimental 13C-NMR values (ppm) of dermacozine P (3), dermacozine B (5), and
dermacozine C (6).
This trend of the 13C-NMR chemical shifts provides additional evidence that the
substituent at C-1 is more electron withdrawing compared to the one in the case of 5 and
6 and keeping with the carboxylic acid substitution at position C-1. Due to the oxidized
phenazine substructure of 3, the carbon atoms at C-7 and C-9 are more deshielded because
of the nitrogen atoms conjugated to them three (N-5) and two bonds (N-10) away, respec-
tively, as opposed to the more shielded aromatic carbons in the case of the more reduced
dermacozine B (5) and C (6) structures (Figure 11). Comparison was made between the
UV–Vis spectra of 3, 5, and 6 in order to obtain further evidence that the structure of 3 was
correct. We found that the electronic structures of 3 and 6 possessed more similarity with
the measured ∆λmax = 5 nm in the visible electromagnetic spectrum, as opposed to the elec-
tronic structures of 3 and 5 based on the ∆λmax = 46 nm measured difference between their
visible absorption maxima [6]. This indicates that the 3-benzoyl-phenazine substructure
of 3 must be substituted in similar fashion with electron withdrawing functional groups
at C-1 and C-6, just like in the structure of 6. Nevertheless, the hypsochromic shift of 6
of 5 nm compared to the one observed in 3 is in keeping with the more electron deficient
phenazine core and the consequently higher degree of conjugation of 3. To satisfy the
observed 13C-NMR chemical shifts of 3, the fit of the linear regression analysis between
the experimental and the ACD Labs software calculated (Neural Network Algorithm,
DMSO-d6) 13C-NMR shifts of 3 as detailed above, the biosynthetic route considerations
(the carboxamide and carboxylic acid functionalities occur at positions C-1 and C-6 in
the shikimic acid biosynthetic pathway of dermacozines) as well as the comparison of
the UV–Vis absorption maxima in the visible electromagnetic spectrum of 3, 5, and 6,
the carboxylic and carboxamide groups are needed to be positioned in the opposite way
between the C-1 and C-6 carbon atoms as opposed to the positioning in dermacozine C (6).
This assignment agrees with the result of the selective NOE experiment, thus placing the
–CONH2 group at position C-6.
The MS/MS fragmentation data of 3 agreed with our proposed structure, as shown
in Figure 9. We were able to identify, among other molecular fragment ions of 3, the
C20H11N2O2+ fragment (measured m/z of [M]+ as 309) that agrees with the loss of an –OH
and a –CONH2 fragment keeping with the proposed –COOH group at position C-1. The
benzoyl substituted core phenazine fragment molecular ion with a molecular formula of
Mar. Drugs 2021, 19, 325 14 of 22
C19N2O+ (measured m/z of [M]+ as 283) following the loss of the –COOH and –CONH2
fragments was also apparent in the spectrum (Figure S25).
Therefore, dermacozine P (3) is the 5N-demethylated and 6-carboxylated, oxidized
analogue of dermacozine B (5) and as such, it was chemically identified as 8-benzoyl-6-
carbamoylphenazine-1-carboxylic acid.
Dermacozine B (5) and C (6) showed antioxidant activity in the DPPH assay as well
as activity against the K562 leukemia cell line as previously described following their
isolation [6]. Given the structural similarity of dermacozine P (3) to these substances,
further investigation of 3 in anti-tumor and radical scavenging studies would be inter-
esting, especially taking into consideration that the synthetic modulation of the related
dermacozine-1-carboxamide derivatives led to increased biological activity in anti-tumor
assays as mentioned earlier (see Introduction).
3. Materials and Methods
3.1. Microorganisms
Pure colonies of Dermacoccus abyssi MT 1.1T were provided on an ISP2 agar plate by
the School of Biology, University of Newcastle.
3.2. Fermentation and Initial Partitioning
A seed culture of Dermacoccus abyssi MT 1.1T was prepared as follows: 25 mL of ISP2
medium (yeast extract 4 g, D-glucose 10 g, malt extract 10 g, MilliQ water 1 L, pH 7.0)
was supplemented with 20 g/L NaCl. The seed culture incubation was carried out in a
50 mL Falcon tube at 28 ◦C and 150 rpm for five days. The large-scale fermentation was
done in six 2 L Erlenmeyer flasks, each of them containing 1000 mL ISP2 medium (yeast
extract 4 g, D-glucose 10 g, malt extract 10 g, MilliQ water 1 L, pH 7.0) supplemented with
35 g/L ocean salt (H2Ocean + Pro Formula with trace elements, The Aquarium Solution
Ltd., Hainault Industrial Estate, Ilford Essex, UK). Each flask was inoculated with 1500 µL
of the first stage seed culture incubated at 28 ◦C with agitation at 150 rpm for 14 days in an
incubator with a transparent glass cover.
The fermentation broth (6 L) was harvested by the addition of 50 g/L Diaion HP20
resin (>250 µm, Alfa Aesar by Thermo Fisher Scientific, Heysham, Lancashire, U tation
for 24 h in a shaker at 28 ◦C and 150 rpm. The HP20 resin was eluted with methanol
(3 × 500 mL) and then with dichloromethane (3 × 500 mL). The successive methanol
and dichloromethane extracts were combined and concentrated under reduced pressure
yielding the crude material (10,256 mg). The crude material was subjected to liquid–
liquid partitioning with the Kupchan method previously used during the isolation of
dermacozine M (14) [8]. The crude material was suspended in 500 mL H2O and extracted
three times with an equal volume of dichloromethane in a 1 L separation funnel. The
resultant H2O layer was then extracted with 3 × 500 mL 2-butanol providing the water
fraction (WF; 3498 mg) and the 2-butanol fraction (WB; 2295 mg). The dichloromethane
layer was dried under reduced pressure. The dried material was dissolved in 300 mL 9:1
methanol:H2O solution and extracted with an equal volume of n-hexane. The n-hexane
fraction was dried under reduced pressure resulting in the n-hexane fraction (FH; 65 mg).
The remainder 300 mL 9:1 methanol:H2O solution after separating it from the n-hexane
layer was adjusted to 1:1 methanol:H2O solution with 120 mL 100% MilliQ water then
extracted with 420 mL dichloromethane three times, which gave the dichloromethane
fraction. The dichloromethane layer was separated and dried under reduced pressure (FD;
379 mg). The remainder of the methanol:H2O layer was dried providing the methanol
fraction (FM; 4019 mg). The dichloromethane fraction (FD; 379 mg) was further sepa-
rated with silica gel chromatography (Fluorochem, 60A 40-63U MW = 60.083) with a
9:1 dichloromethane:methanol mobile phase as follows: a Quickfit XA42 29/32, 19/26,
19 mm × 500 mm (Fisher Scientific, Loughborough, UK) glass column was used, packed
with 200 g silica (~550× of the mass of the FD fraction), with a flow rate of ~0.8 mL/min,
collected into 10 mL vials. Bands were collected based on their visible colors but they also
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showed fluorescence under UV light (360 nm). In the silica chromatography of the FD
fraction, 35 fractions were obtained (S1–S35). These fractions were combined based on TLC
(thin layer chromatography) experiments and purified further, as detailed in the Section 3.5
(please see the TLC plate of the FD fraction with dichloromethane:methanol 9:1 mobile
phase and the colorful bands in Theme S2).
3.3. Instrumentation
High performance liquid chromatography: Semi-preparative Gradient Agilent HPLC
apparatus (1100 series, Agilent—Santa Clara, Cequipped with binary pump, diode array
detector (G1315B, Agilent—Santa Clara, CSunfire C18 reversed phase column (5 µm, 10 ×
250 mm), and ACE HL C18 reversed phase column (5 µm, 10 × 250 mm).
Nuclear magnetic resonance spectrometers: For the structure determination of 1 and
2, a Bruker 800 MHz NMR spectrometer (Bruker Biospin—Billerica, Merating with a 5 mm
TCI He Cryoprobe was used. 1D 1H-NMR and magnitude 2 D NMR experiments were
run apart from the 1H-13C HMBC of 1, where an additional phase sensitive experiment
was conducted. In the case of compound 3, 1 D 1H-NMR and magnitude mode 2 D NMR
experiments were run including a selective NOESY experiment with a Bruker 600 MHz
NMR spectrometer (Bruker Biospin—Billerica, MCE III HD operating with a N2 Cryoprobe.
HSQC experiments were obtained using 2D H-1/X correlation via the double inept transfer
phase sensitive using Echo/Antiecho-TPPI gradient selection; with decoupling during
acquisition; using trim pulses in inept transfer; with multiplicity editing during selection
step, shaped pulses for inversion on f2—channel for matched sweep adiabatic pulses; for
HMBC, experiments were obtained with 2D H-1/X correlation via heteronuclear zero and
double quantum coherence, phase sensitive and magnitude mode in the case of 1, and mag-
nitude mode for 2 and 3, using Echo/Antiecho gradient selection with two-fold low-pass
J-filter to suppress one-bond correlations with no decoupling during acquisition [44–49].
Liquid chromatography-mass spectrometry: 1 and 2 were analyzed with a Bruker
MAXIS II qTOF LC-MS instrument. LC-qTOF utilizes a Phenomenex Kinetex XB-C18
column (2.6 µm; 100 × 2.1 mm) with a mobile phase of 5% acetonitrile + 0.1% formic
acid to 100% acetonitrile + 0.1% formic acid with a run time of 11 min. 3 was analyzed
with a Thermo Instruments MS system (LTQ-XL Orbitrap Discovery) coupled to a 1290
Infinity Agilent UHPLC system, utilizing a Phenomenex Kinetex XB-C18 column (2.6 µm;
100 × 2.1 mm) with a mobile phase of 5% acetonitrile + 0.1% formic acid to 100% acetoni-
trile + 0.1% formic acid in 25 min. The analytes were diluted to 0.01 mg/mL concentration
with methanol.
Infrared spectra were recorded in ethanol with a Perkin Elmer Spectrum Two FTIR
spectrometer Perkin Elmer, MVis Spectroscopic data were recorded in ethanol using a
Thermo Scientific Evolution 201 UV–Visible Spectrophotometer Thermo, M. Computational
Calculations
A Macromodel module implemented in the Maestro Quantum mechanical software
(Maestro Schrödinger LLC, New York, N was used for conformational searches [21]. The
calculations were carried out by using an OPLS 2005 force field with ethanol as the solvent.
A torsional enhanced sampling with 1000 or 10,000 steps was fixed using an energy
window of 4.0 kcal/mol. Molecular geometry optimizations were performed at the DFT
theoretical level using the Gaussian 09W package with a HSEH1PBE/cc-pVDZ auto for
energy and frequency calculations. After removing redundant conformers and those with
imaginary frequencies, theoretical Boltzmann energy population-weighted UV–Vis spectra
were calculated by using PBEPBE/6-311++g(3d,2p) with 24 states [22]. The open software
SpecDis V.1.71 (Berlin, Germany, 2017, https:/specdis-software.jimdo.com, (accessed on the
7th y 2020 and on the 14 April 2021)) was used to obtain the graphical theoretical UV–Vis
curves [23].
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3.4. Isolation of Compounds
Dermacozine N (1) was obtained with further purification of the initial silica fractions
detailed in Section 3.2 as follows: the first fraction (S1) of the initial FD fractionation with
silica chromatography gave dermacozine M (14) as reported by Abdel-Mageed et al. [8].
The S2–S3 deep purple colored fractions of the initial silica chromatography as described
in Section 3.2 were combined based on TLC chromatography, dried in a N2 drier (57.3 mg),
and further partitioned with silica glass column chromatography. A Quickfit CR 20/30
19/26 glass column was used, packed with ~20 g silica (~350× of the mass of the initial
mass of the combined S2–S3 silica chromatography FD fraction), and the mobile phase
was 9:1 dichloromethane:methanol also in this case. In this experiment, fifteen (SA1–SA15)
fractions were collected, each into 7 mL vials with a flow rate of ~0.4 mL/min. The SA9–
SA11 pink colored fractions of this experiment were combined based on TLC. Keeping
this fraction in a cold room at 4 ◦C, a pink precipitate appeared, which was centrifuged at
10,000 rpm for 15 min. Upon removal of the supernatant and drying the substance in N2
drier, the substance appeared to be a pure compound (1.6 mg) according to the 1H-NMR
and the LC-HRESI-MSn measurements (Figures S1 and S6).
Dermacozine O (2) was obtained with further purification of the initial silica fractions
detailed in Section 3.2 as follows: the S5–S8 red colored silica fractions (28.2 mg) were
combined based on TLC chromatography, dried in a N2 drier, and subjected to HPLC
purification. High performance liquid chromatography purification of dermacozine O (2)
was carried out isocratically with a methanol/H2O 60%/40% + 0.1% trifluoroacetic acid
solvent system over 40 min with 1.8 mL/min flowrate, and with Sunfire C18 reversed phase
column (5 µm; 110 × 250 mm). Peak detection and UV–Vis trace analysis was carried out
at the wavelengths of 254 ± 5 nm, 280 ± 5 nm, 330 ± 5 nm, 350 ± 5 nm, and 530 ± 25 nm.
Material collection was automated based on UV–Vis peak appearance versus time. The
HPLC fraction with RT = 31.9 min yielded (3.1 mg) the pure compound (see Figures S13,
S16 and Theme S3).
Dermacozine P (3) was obtained with further purification of the initial silica fractions
detailed in Section 3.2 as follows: the initial S4 (7 mg) blue colored silica fraction of the
dichloromethane Kupchan fraction (FD) was dried in N2 drier and subsequently repurified
with High performance liquid chromatography. The HPLC purification of dermacozine
P (3) was carried out with a gradient from the initial solvent ratio of 0% methanol and
95% H2O + 5% methanol + 0.05% trifluoro-acetic acid to 100% methanol and 0% H2O
over 40 min with 2 mL/min flowrate, and with an ACE C18 HL reversed phase column
(5 µm; 110 × 250 mm). Peak detection and the UV–Vis trace analysis was carried out at
the wavelengths of 250 ± 5 nm, 280 ± 5 nm, 500 ± 25 nm, 550 ± 25 nm, and 600 ± 25 nm.
Material collection was automated based on UV–Vis peak appearance versus time. The
HPLC fraction with RT = 15.9 min yielded (3.4 mg) the pure compound (see Figures S24,
S26 and Theme S4).
3.5. Cytotoxic Activity of Dermacozines against Human Tumor Cell Lines
The cytotoxic activity of dermacozines N (1) and O (2) against five different human
cancer cell lines, namely A549 (lung carcinoma), A2058 (metastatic melanoma), MCF7
(breast adenocarcinoma), MIA PaCa-2 (pancreatic carcinoma), and HepG2 (hepatocyte
carcinoma) (obtained from ATCC, Manasas, V [50] was studied based on the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay [51]. The compounds were
tested as a 10-point dose-response curve ( 12 serial dilutions) starting at a concentration
of 20 µg/mL in triplicate. IC50 values were determined as previously described [50].
Dermacozine P (3) was not tested against cancer cell lines.
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3.6. Chemical Characterization of Compounds
Dermacozine N (1): pink amorphous powder, 1.6 mg; LC-HRESI-MSn (qTOF, Bruker),
m/z measured 386.1247 [M + H]+, 408.1068 [M + Na]+, 772.2448 [2M + H]+, 793.2225 [2M +
Na]+, ∆ = −0.3 ppm for calculated m/z of [M + H]+ 386.1248; DBE = 17; MF = C21H15O3N5.
UV λmaxEtOH = 729, 660, 577, 364, 309 nm. IREtOH = 3439, 2988, 1662, 1066, 1039, 544, 521,
471, 463 cm−1. 1H- and 13C-NMR data (DMSO-d6), see Table 1.
Dermacozine O (2): ink blue amorphous powder, 3.1 mg; LC-HRESI-MSn (qTOF,
Bruker) m/z 398.1125 [M + H]+, ∆ = −2.5 ppm for calculated m/z of [M + H]+ 398.1135,
DBE = 18; MF = C23H15O4N3. UV λmaxEtOH = 644, 563, 463, 396(sh), 308 nm. IREtOH = 2971,
1989, 1949, 1091, 1048, 882, 524, 501, 481, 453 cm−1. 1H- and 13C-NMR data (DMSO-d6), see
Table 1.
Dermacozine P (3): purplish amorphous powder, 3.4 mg; LC-HRESI-MSn (Orbitrap,
Xcalibur) m/z 372.0990 [M + H]+, ∆ = 3.0 ppm for calculated m/z of [M + H]+ 372.0979;
DBE = 17; MF = C21H13O4N3. UV λmaxEtOH = 465, 415(sh), 363 nm. IREtOH = 3440, 3178,
1661, 872, 757, 603, 575, 556, 534, 523, 465, 437, 410 cm−1. 1H- and 13C-NMR data (DMSO-d6),
see Table 1.
Table 1. NMR spectroscopic data for dermacozine N (1) (800 MHz, DMSO-d6), dermacozine O (2) (800 MHz, DMSO-d6),
and dermacozine P (3) (600 MHz, DMSO-d6).†: Calculated with ACD Labs software, Nural Nework Algrithm, DMSO-d6
(Chemical shift is not observed).
N.
Dermacozine N (1) Dermacozine O (2) Dermacozine P (3)
δC, mult δH, mult (J in Hz) δC, mult δH, mult (J in Hz) δC, mult δH, mult (J in Hz)
1 128.9, C 129.6, C 131.5, C
2 125.9, CH 7.88 (dd, 7.6, 1.3) 126.6, CH 7.87 (dd, 7.5, 1.1) 134.9, CH 8.74 (dd, 7.0, 1.3)
3 128.4, CH 7.47 (td, 8.3, 7.6) 131.3, CH 7.78 (td, 8.5, 7.5) 132.4, CH 8.21 (td, 7.0, 8.6)
4 118.0, CH 7.55 (dd, 8.3, 1.3) 120.3, CH 7.97 (dd, 8.5, 1.1) 132.6, CH 8.55 (dd, 8.6, 1.3)
4a 134.4, C 134.0, C 142.4, C
5a 135.5, C 139.5, C 140.7, C
6 109.8, C 100.4, C 129.8, C †
7 148.1, C 139.6, C 131.3, CH 8.65 (d, 1.9)
8 149.8, C 134.5, CH 7.21 (d, 9.7) 135.6, C †
9 105.9, CH 6.79, s 129.7, CH 7.24 (d, 9.7) 135.1, CH 8.95 (d, 1.9)
9a 151.6, C 150.6, C 144.0, C †
10a 135.1, C 135.3, C 141.2, C
11 166.3, C 167.2, C 165.5, C
12
A 7.70, brs COOH,not observed COOH,
not observedB 9.31, brs
13 168.3, C † 163.6, C † 166.6, C
14 A 7.65, brs A 8.03, brs
B 7.98, brs 11.27, brs B 9.47, brs
15 143.3, C 163.1, C † 194.4, C
16 115.0, CH 7.12 (dd, 7.6, 1.5) 122.6, C 136.3, C
17 127.9, CH 7.19 (ddd, 7.6, 7.4, 1.6) 134.1, C 130.0, CH 7.95 (dd, 7.6, 1.3);
18 125.3, CH 7.15 (ddd, 7.6, 7.4, 1.5) 131.3, CH 7.30 (dd, 7.4, 1.3) 128.7, CH 7.66 (td, 7.6, 1.3)
19 127.2, CH 7.30 (dd, 7.6, 1.6) 128.2, CH 7.47 (td, 7.4, 1.3) 133.5, CH 7.78 (td, 7.6, 1.3)
20 134.8, C 127.9, CH 7.41 (td, 7.4, 1.3) 128.7, CH 7.66 (td, 7.6, 1.3)
21 128.2, CH 7.47 (td, 7.4, 1.3) 130.0, CH 7.95 (dd, 7.6, 1.3);
22 131.3, CH 7.30 (dd, 7.4, 1.3)
23 39.5, CH3 3.68, s 45.9, CH3 3.67, s - -
3.7. Regression Models Used in the Structure Elucidation
We used a linear regression model in the case of dermacozine N (1). The experimental*
13C-NMR chemical shifts of 1 were correlated to the ACD Labs software calculated ones
(ACD/Structure Elucidator, version 2019.2.0, Neural Network Algorithm, solvent used for
simulation: DMSO-d6) in their theoretically possible structures (A–W). The simple linear
regression model showed clear difference between the possible structures keeping with the
results of other modalities in the structure elucidation process. The correlation coefficient
obtained was R2 = 0.99 (See Section 2.1).
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In the case of dermacozine O (2), we compared its experimental 13C-NMR chemical
shift values to the ones reported in structures 8, 9, and 10 [6] due to their structural similarity.
The experimentally not observed 13C-NMR shifts (e.g., C-13 and C-15 in 2) were excluded
from the regression analysis, and since in dermacozine M (14) C-3 was calculated with ACD
Labs software and contains an additional benzoyl ring at C-3, we excluded this structure
from the calculations. A multiple regression test was carried out that showed significant
similarity between dermacozine O (2) and dermacozine E (8) based on the p-value and
t-test (see Section 2.2).
In the case of dermacozines P (3), linear regression was done between the ACD
Labs software calculated (ACD/Structure Elucidator, version 2019.2.0, Neural Network
Algorithm, solvent used for simulation: DMSO-d6) and its experimentally observed 13C-
NMR chemical shift values. The R2 value obtained was R2 = 0.98 (See Section 2.3).
*The experimental 13C-NMR values for the statistical calculations were measured in
DMSO-d6 in the case of structures 1, 2, and 3.
4. Conclusions
Dermacoccus abyssi MT 1.1T is a piezotolerant, halotolerant Actinomycete from the
deepest part of the Earth, the Mariana Trench, Challenger Deep. Since the discovery
of the strain in 2006, more than a dozen novel, highly colored dermacozines have been
isolated from it. This work provides evidence that the bacterium ability of producing new
compounds is still not exhausted yet.
Herein, we report on the isolation of three new dermacozines; dermacozine N (1),
dermacozine O (2), and dermacozine P (3) when the strain was seed cultured in 20 g/L
containing NaCl medium, followed by the cultivation in ISP2 medium, approximating the
salinity of its usual habitat of 34.7‰. The difficulty of structure elucidation arising from the
polycyclic nature of dermacozines was overcome by the combined approach of utilizing
linear/multiple linear regression of experimental and ACD Labs software calculated 13C-
NMR chemical shifts, (TD-DFT) UV–Vis spectral simulation, 1D/2D NMR, LC-HRESI-MSn,
biosynthetic route considerations, which step by step offered complementary evidence for
our structural assignments.
In dermacozine N (1)—whose phenoxazine skeleton is unprecedented in nature to the
best of our knowledge—the [b]benzopyrazine substitution of the core phenoxazine resulted
in UV–Vis absorption maxima in the near infrared (NIR) region. Phenoxazines have been
reported to exhibit non-linear optical properties; nevertheless the structure of dermacozine
O (2) is highly similar to those of dermacozines E (8), F (9), G (10), which were suggested
to also exhibit non-linear optic properties in computational chemistry studies. This gives
a perspective of investigating 1 and 2 in opto-electronics and second harmonic genera-
tion. Given the NIR absorption spectrum of 1, the reported solvatochromic behavior, and
bathochromic shift observed in acidic conditions of related phenoxazine skeletons, 1 would
be an outstanding candidate to conduct research on in biosensing chemistry, biomolecu-
lar labelling, and in vivo metabolic mapping at the cellular level. Compound 1 showed
weak activity against melanoma (A2058) and hepatocellular human carcinoma cell lines
(HepG2) with IC50 values of 51 and 38 µM, respectively. Dermacozine P (3) is the oxidized,
5N-demethylated, and C-6 carboxylated derivative of dermacozine B (5). Based on the
literature data and cytostatic activities of the previously reported dermacozine derivatives
and that synthetic modulation of dermacozine-1-carboxamides increased the compounds’
anti-tubulin activity, further anti-tumor studies involving synthetic modulation of the
compounds of dermacozine N (1), O (2), and P (3) would be promising.
Fascinating research is being conducted in various fields of chemistry to be able to
utilize the novelty of these vividly colored compounds including opto-electronics, computa-
tional chemistry, biosensing chemistry, and medicinal chemistry exhibiting exciting results.
Whilst the potential use of the colorful dermacozines in chemistry keeps stimulating the
interest of researchers, their biological role in the mesmerizing depth of the hadal zone
remains unknown.
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MS/MS of dermacozine N (1) (qTOF, Bruker), Figure S3A: Proposed MS fragmentation pathway of
dermacozine N (1) showing loss of a (-ON(C6H4)-) fragment, Figure S3B: Mass error between the
calculated (Chemdraw modeled) and experimental (qTOF) m/z ratio of dermacozine N (1), Figure S4:
UV–Vis spectrum of dermacozine N (1) in EtOH, Figure S6: Dermacozine N (1) 1H-NMR spectrum
(800 MHz, DMSO-d6), Figure S7: 1H-13C HSQC spectrum of dermacozine N (1) (800 MHz, DMSO-d6),
Figure S8: 1H-13C HMBC (magnitude mode) spectrum of dermacozine N (1) (800 MHz, DMSO-d6),
Figure S9: 1H-13C HMBC spectrum of dermacozine N (1) with J = 2 Hz (800 MHz, DMSO-d6),
Figure S10: 1H-1H COSY spectrum of dermacozine N (1) (800 MHz, DMSO-d6), Figure S11: 1H-1H
NOESY spectrum of dermacozine N (1) (800 MHz, DMSO-d6), Figure S12: 1H-15N HMBC spectrum
of dermacozine N (1) (800 MHz, DMSO-d6), Figure S13: LC-MS analysis of dermacozine O (2) (qTOF,
Bruker), Figure S14: UV-Vis spectrum of dermacozine O (2) in EtOH, Figure S15: IR spectrum of
dermacozine O (2) in EtOH, Figure S16: 1H-NMR spectrum of dermacozine O (2) (800 MHz, DMSO-
d6), Figure S17: 1H-13C HSQC spectrum of dermacozine O (2) (800 MHz, DMSO-d6), Figure S18:
1H-13C HMBC spectrum of dermacozine O (2) (800 MHz, DMSO-d6), Figure S19: Long Range 1H-13C
HMBC correlations of dermacozine O (2) with J = 2 Hz (800 MHz, DMSO-d6), Figure S20: 1H-1H
COSY spectrum of dermacozine O (2) (800 MHz, DMSO-d6), Figure S21: 1H-15N HMBC spectrum of
dermacozine O (2) (800 MHz, DMSO-d6), Figure S22: UV-Vis spectrum of dermacozine P (3) in EtOH,
Figure S23: IR spectrum of dermacozine P (3) in EtOH, Figure S24: LC-MS analysis of dermacozine
P (3) (Orbitrap, Xcalibur), Figure S25: MS/MS analysis of dermacozine P (3) (Orbitrap, Xcalibur),
Figure S26: 1H-NMR spectrum of dermacozine P (3) (600 MHz, DMSO-d6), Figure S27: 1H-13C
HSQC spectrum of dermacozine P (3) (600 MHz, DMSO-d6), Figure S28: 1H-13C HMBC spectrum
of dermacozine P (3) (600 MHz, DMSO-d6), Figure S29: 1H-1H COSY spectrum of dermacozine P
(3) (600 MHz, DMSO-d6), Figure S30: 1D-NOESY spectrum of dermacozine P (3) (600 MHz, DMSO-
d6) from irradiation of the signal at 8.03 ppm, Figures S31-S33: 13C-NMR δ calculated values of
dermacozine A–P (1–14) using the ACD Labs software with Neural Network Algorithm, solvent
DMSO-d6, Figures S34-S38: 13C-NMR δ calculated values of possible structures (A–W) of derma-
cozine N (1), using the ACD Labs software with Neural Network Algorithm, solvent DMSO-d6,
Table S1: Comparison between calculated vs. experimental 13C-NMR δ values of dermacozines
A–J (4–13), Figure S39: Linear regression graphics between ACD Labs (Neural Network Algorithm,
DMSO-d6) calculated vs. experimental 13C-NMR δ values of dermacozine A-H (4–11), Figure S40:
Linear regression graphics between ACD Labs (Neural Network Algorithm, DMSO-d6) calculated
vs. experimental 13C-NMR δ values of dermacozine I & J (12–13), Table S2: Comparison between
the experimental 13C-NMR δ values of dermacozine N (1) vs. the calculated ones of possible struc-
tures A, D, E, G, H, I, J, K, N, P, Q, V, W by ACD Labs (Neural Network Algorithm, DMSO-d6),
Figure S41: Linear regression graphics between 13C-NMR δ experimental values of dermacozine
N (1) vs. the ACD Labs calculated ones (Neural Network Algorithm, DMSO-d6) (4–13), Figure S42:
Linear regression graphics between 13C-NMR δ experimental values of dermacozine N (1) vs. the
ACD Labs (Neural Network Algorithm, DMSO-d6) calculated ones for possible structures of N, P,
Q, V, W, Table S3: Absolute error and the standard deviation of the error from the mean between
the calculated (Structure W) and the experimental dermacozine N (1) 13C-NMR chemical shifts,
Table S4: Experimental values of 13C-NMR δ chemical shifts of dermacozines E (8), F (9), G (9),
and O (2) for multiple regression and t-test, Figure S43: Multiple regression analysis between the
experimental 13C-NMR δ values of dermacozines E (8), F (9), G (9) as independent variables and
those of dermacozine O (2) as dependent variables, Table S5: Residuals between the observed and
predicted values of 13C-NMR δ of dermacozines E (8), F (9), G (9) as independent variables and
those of dermacozine O (2) as dependent variables, Table S6: Comparison between experimental and
the ACD Labs calculated 13C-NMR δ chemical shift values of dermacozines P (3) (Neural Network
Algorithm, DMSO-d6), Figure S44: Linear regression graphics between the experimental 13C-NMR
δ chemical shifts of dermacozine P (3) and the ACD Labs calculated 13C-NMR δ values (Neural
Network Algorithm, DMSO-d6), Table S7: Absolute error and the standard deviation of the error from
the mean between the calculated and the experimental dermacozine P (3) 13C-NMR chemical shifts,
Figure S45: Evaluation of the cytotoxic activity of dermacozine N (1) against human (A) Melanoma
(A2058) and (B) Hepatocellular carcinoma (HepG2) cell lines (IC50 graphs), Table S8: Experimen-
tal NMR spectroscopic data for dermacozine N (1) with HMBC, COSY, and NOESY correlations
(800 MHz, DMSO-d6), Table S9: Experimental NMR spectroscopic data for dermacozine O (2) with
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HMBC and COSY correlations (800 MHz, DMSO-d6), Table S10: Experimental NMR spectroscopic
data for dermacozine P (3) with HMBC and COSY correlations (600 MHz, DMSO-d6), Figure S46:
Workflow of dermacozine N (1) structure determination, Figure S47: Workflow of dermacozine O
(2) structure determination, Figure S48: Workflow of dermacozine P (3) structure determination,
Theme S1: Dermacozine N (1) H-9 and NH2-12 distance (modeled with Chemdraw, Chem 3D),
Theme S2: TLC plate of the initial FD fraction following Kupchan liquid–liquid partitioning, showing
the colorful bands where the dermacozines were isolated from (left) and the same TLC plate under
UV 360 nm light (right), Theme S3: HPLC chromatogram for the isolation of dermacozine O (2),
Theme S4: HPLC chromatogram for the isolation of dermacozine P (3).
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